Symposium 30: Pharmacogenomics Clinical Implementation Programs: Progress and future developments
Tracks
Track 6
| Friday, July 17, 2026 |
| 11:15 AM - 1:15 PM |
Details
Pharmacogenomics has progressed extensively over the past few decades especially in the discovery sciences and in population diversity having regiospecific clinical implications. Although discovery aspects have been illuminating, the implications for the management of patients have been local and invariably not national. However, over the past few years progress is being made at the national level. This symposium will address clinical implementations programs that have commenced or are commencing in UK, Europe, Africa and, Australia & New Zealand. It will highlight lessons learnt from the initiation and development of programs to their national implementation with shortcomings noted and addressed. This symposium is the initiative of the IUPHAR Pharmacogenetics, Drug Metabolism and Transport Committee.
Speaker
Prof Adrián Llerena
Extremadura University Hospital Medical School
Pharmacogenetic Clinical Implementation for all: experience in the Spanish Health Service
Biography
Adrián LLerena is the Director of INUBE Extremadura Biosanitary Research Institute and the Clinical Research Center in the University Hospital, Badajoz Spain. He is also Professor of Pharmacology and Clinical Pharmacology in the Medical School of the University of Extremadura Spain and it was part time in the University of Beira Interior, Portugal, between 1989 to 1993 did his post doc at Karolinska Institute Sweden focusing on Clinical Pharmacogenetics. He has also been Visiting Professor in different Universities in USA such as University of California at Los Angeles 2004 Mount Sinai Medical School at NY 2005 and Miller Medical School at Miami 2006, UNC North Caroline and in Latin America such as UNAM in Mexico San Marcos in Peru Chile Brazil etc. He is also coordinating the RIBEF Ibero-American network of Pharmacogenetics since 2006. He served in different Scientific societies as Ibero-American Society of Pharmacogenomics. Former Vice-president of the Spanish Society of Clinicial Pharmacology and President of the Spanish Society for Pharmacogenetics and Pharmacogenomics (2019-23). Coordinator of the IMPaCT WP05-BioFRAM-MedeA Pharmacogenetics Implementation Projects in Spanish Health System.
Session chair
Deirdre Landsberg
University of South Australia
Andrew Somogyi
University Of Adelaide
